Qufu Hongly Chemical Industry Co.,Ltd.

　　Founded in 1995, Qufu Hongly Chemical Industry Co.,Ltd. is located in the celebrated historic and cultural place of interest，Qufu, China with a total area of 30,000m2. It has fixed capital equal to 60 million RMB and its annual output value 150 million RMB.

　　Hongly is specialized in the development and manufacture of APIs and intermediates. The product list includes Pyrrolidine, Carvedilol, Ondansetron, Granisetron, Naftopidil, Lisinopril, Bicalutamide, Toremifene Citrate, Levosulpiride, Phthalimide and phthalimide potassium salt, and intermediates. Meanwhile, Hongly would like to be consigned to do contract manufacture for the customers.

　　Equipped with experienced technicians, advanced facility, a strict QC/QA system and I/E license, we have passed ISO9001: 2000 in 2002. Hongly will continue to improve its quality system based on ISO9001:2000 to hit quality targets and achieve sustainable development. Moreover, Hongly always acts according to ICH-Q7H-international GMP for Active Pharmaceutical Ingredients (API) in its manufacture.

　　With the expanding of the market, Hongly occupies a stable share in domestic and foreign market. Thanks to excellent quality and sincere and perfect service, our products are popular all over the world. We even have established long-term companionship with some world famous pharmaceutical corporations. And we sincerely look forward to cooperating and booming with more and more outstanding clients at home and abroad.

　　We are investing RMB50 million to produce Pyrrolidine and N-methylpyrrolidine. The annual output is supposed to be 2000 metric tons for Pyrrolidine and 500 metric tons for N-methylpyrrolidine. Both assay is above 99%. We are looking forward to cooperating with all the customers.